Synthetic Biology and the Frontiers of Technology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Physiology of Highly Radioresistant Escherichia Coli After Experimental Evolution for 100 Cycles of Selection
Lawrence Berkeley National Laboratory Recent Work Title Physiology of Highly Radioresistant Escherichia coli After Experimental Evolution for 100 Cycles of Selection. Permalink https://escholarship.org/uc/item/5bj102bg Authors Bruckbauer, Steven T Martin, Joel Minkoff, Benjamin B et al. Publication Date 2020 DOI 10.3389/fmicb.2020.582590 Peer reviewed eScholarship.org Powered by the California Digital Library University of California fmicb-11-582590 September 17, 2020 Time: 16:43 # 1 ORIGINAL RESEARCH published: 22 September 2020 doi: 10.3389/fmicb.2020.582590 Physiology of Highly Radioresistant Escherichia coli After Experimental Evolution for 100 Cycles of Selection Steven T. Bruckbauer1, Joel Martin2, Benjamin B. Minkoff1,3, Mike T. Veling4, Illissa Lancaster1, Jessica Liu1, Joseph D. Trimarco1†, Brian Bushnell2, Anna Lipzen2, Elizabeth A. Wood1, Michael R. Sussman1,3, Christa Pennacchio2 and Michael M. Cox1* Edited by: Vasco Ariston De Carvalho 1 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States, 2 DOE Joint Genome Institute, Azevedo, Berkeley, CA, United States, 3 Center for Genomic Science Innovation, University of Wisconsin School of Medicine and Public Federal University of Minas Gerais, Health, Madison, WI, United States, 4 Department of Systems Biology, Harvard Medical School, Boston, MA, United States Brazil Reviewed by: Bing Tian, Ionizing radiation (IR) is lethal to most organisms at high doses, damaging every cellular Zhejiang University, China macromolecule via induction of reactive oxygen species (ROS). Utilizing experimental Vera Y. Matrosova, evolution and continuing previous work, we have generated the most IR-resistant Henry M. Jackson Foundation for the Advancement of Military Escherichia coli populations developed to date. After 100 cycles of selection, the Medicine, United States dose required to kill 99% the four replicate populations (IR9-100, IR10-100, IR11- Suzanne Sommer, Université Paris-Saclay, France 100, and IR12-100) has increased from 750 Gy to approximately 3,000 Gy. -
Biology, Adaptability, and the Economic Applications of Tardigrades in Future
Journal of Science and Technology ISSN: 2456-5660 Volume 06, Issue 01, Jan-February 2021 www.jst.org.in DOI: https://doi.org/10.46243/jst.2021.v6.i1.pp109-117 Biology, Adaptability, and The Economic Applications of Tardigrades In Future Ms. Afreen s. Shaikh1, Dr. Anis B. Chaoudhery2 1(Department of Oceanography, Sindhu Swadhay Sanstha, Kalyan, University of Mumbai. District Thane, Maharashtra, India) 2(Department of zoology, G.M.MominWomens college, Bhiwandi, University of Mumbai, District Thane, Maharashtra, India) 2Corresponding Author: [email protected] To Cite this Article Ms. Afreen s. Shaikh, Dr. Anis B. Chaoudhery, “Biology, Adaptability, and The Economic Applications of Tardigrades In Future”, Journal of Science and Technology, Vol. 06, Issue 01, Jan-February 2021, pp109-117 Article Info Received: 28-08-2020 Revised: 18-11-2020 Accepted: 26-11-2020 Published: 27-12-2020 Abstract: Tardigrades are small microscopic creatures also known as moss piglets or water bears. They are extremophiles and well known for its survivability. After successfully ruling the space tardigrades are now expected to save lives. From being a ‘survivor’ tardigrade is now headed to be a ‘savior’. This survivability is due to a special type of sugar known as “Trehalose”. Trehalose can be found in extremophiles organisms including tardigrades. The unique feature of this sugar is the ability to preserve biological molecules. One of the big applications of the tardigrades are the “dry vaccine”. Our world is struggling through a big crisis of covid-19 vaccine, it is next to impossible to make the highest demanded vaccine available to every corner of the earth at the low-temperature range in such a short period of time, and according to WHO half of the vaccines get wasted due to the cold chain method So, we can implement these dry vaccines for covid-19, to reduce the freezing cost, increasing the shelf life of vaccine and make every vaccine reach to needy in a live condition. -
Cryonics Magazine, Q3 1998
Letters to the Editor To the Editor: him. Oddly, both authors share one article and byline: Thomas Donaldson. s the Hitchhiker’s Guide Your readers may have noticed certain to the Galaxy suggests, sharp disagreements in Cryonics (2nd Qtr. —K. Eric Drexler A 1998). “Don’t Panic.” Despite the In that issue, Author 1 calls for further Thomas Donaldson replies: title of this issue’s feature story, study of how freezing damage could be “The Failure of Cryonics,” I repaired by nanomedical technologies. He It seems to me that my statements are don’t believe that cryonics has notes that this effort “...need not actually quoted out of context, and in many cases solve [the problem of inferring neural con- context is important. failed and I don’t believe that nectivity] in practice,” which would be be- First of all, there is an issue of what it will fail. yond current technological abilities, and “nanotechnology” is to include. If Why am I printing this ar- asks instead for scenarios that start with nanotechnology means the manipulation of ticle then? Because I do be- “the damage that really occurs, then specify matter on a molecular scale, chemists have lieve that the cryonics com- the biochemicals or other concrete items” now done that for over a century, and their enabling the required inference. abilities to do so have increased a great munity holds valid opinions Author 2, in contrast, argues that “only deal. Biochemists have come on the scene besides my own. As I prom- solving the problem theoretically would be and proceeded to manipulate those chemi- ised from my first issue, Cry- cheating,” and asks not for specifications, cals which play a major role in our own onics is aimed at all cryonicists, but for “experiments” in this area. -
Physiology of Highly Radioresistant Escherichia Coli After Experimental Evolution for 100 Cycles of Selection
fmicb-11-582590 September 17, 2020 Time: 16:43 # 1 ORIGINAL RESEARCH published: 22 September 2020 doi: 10.3389/fmicb.2020.582590 Physiology of Highly Radioresistant Escherichia coli After Experimental Evolution for 100 Cycles of Selection Steven T. Bruckbauer1, Joel Martin2, Benjamin B. Minkoff1,3, Mike T. Veling4, Illissa Lancaster1, Jessica Liu1, Joseph D. Trimarco1†, Brian Bushnell2, Anna Lipzen2, Elizabeth A. Wood1, Michael R. Sussman1,3, Christa Pennacchio2 and Michael M. Cox1* Edited by: Vasco Ariston De Carvalho 1 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, United States, 2 DOE Joint Genome Institute, Azevedo, Berkeley, CA, United States, 3 Center for Genomic Science Innovation, University of Wisconsin School of Medicine and Public Federal University of Minas Gerais, Health, Madison, WI, United States, 4 Department of Systems Biology, Harvard Medical School, Boston, MA, United States Brazil Reviewed by: Bing Tian, Ionizing radiation (IR) is lethal to most organisms at high doses, damaging every cellular Zhejiang University, China macromolecule via induction of reactive oxygen species (ROS). Utilizing experimental Vera Y. Matrosova, evolution and continuing previous work, we have generated the most IR-resistant Henry M. Jackson Foundation for the Advancement of Military Escherichia coli populations developed to date. After 100 cycles of selection, the Medicine, United States dose required to kill 99% the four replicate populations (IR9-100, IR10-100, IR11- Suzanne Sommer, Université Paris-Saclay, France 100, and IR12-100) has increased from 750 Gy to approximately 3,000 Gy. Fitness *Correspondence: trade-offs, specialization, and clonal interference are evident. Long-lived competing sub- Michael M. Cox populations are present in three of the four lineages. -
Program BAA Template
Broad Agency Announcement Biostasis BIOLOGICAL TECHNOLOGIES OFFICE HR001118S0034 March 16, 2018 HR001118S0034, Biostasis TABLE OF CONTENTS PART I: OVERVIEW INFORMATION ....................................................................................3 PART II: FULL TEXT OF ANNOUNCEMENT.......................................................................4 1. Funding Opportunity Description.....................................................................................4 1.1. Program Overview ......................................................................................................4 1.2. Program Structure and Technical Approach ...........................................................5 1.3. End of Phase Demonstrations ....................................................................................7 1.4. Program Metrics..........................................................................................................8 2. Award Information...........................................................................................................12 2.1. General award information......................................................................................12 2.2. Fundamental Research .............................................................................................13 3. Eligibility Information......................................................................................................13 3.1. Eligible Applicants ....................................................................................................13 -
ROGER LARKEN CHANG, Ph.D
Roger L. Chang, Harvard Medical School Curriculum Vitae | p. 1 of 9 ROGER LARKEN CHANG, Ph.D. 210 Longwood Avenue, Armenise 623 [email protected] Department of Systems Biology Phone: 858-349-5380 Harvard Medical School http://silver.med.harvard.edu/index.php/people/#RLC Boston, MA 02115 Place of Birth: Euless, TX EDUCATION 2012 Ph.D. Bioinformatics and Systems Biology, University of California San Diego Co-Advisors: Bernhard Ø. Palsson, Ph.D. and Philip E. Bourne, Ph.D. Thesis: Structural Systems Biology Perspective on the Metabolic Impact of Physicochemical Stress 2005 B.A. Molecular and Cell Biology (genetics & development emphasis), University of California Berkeley RESEARCH EXPERIENCE Research associate and associate lab director, Harvard Medical School 2018-present Primary Projects: • Design of intrinsically disordered proteins (IDPs) to induce cryptobiosis in human cells: developed 5-year $15M proposal, acted as project manager, performed computational analysis and design of IDPs, and enzyme stabilization assays LSRF postdoctoral research fellow, Harvard Medical School 2013-2018 Advisor: Pamela A. Silver, Ph.D. Primary Projects: • Discovery of viral-encoded suppressors of innate immunity in humans: helped develop protein structure- based prediction method to identify immunosuppressors, developed automated gene expression construct design pipeline, advised on development of unsupervised learning analysis of high-throughput microscopy imaging data to establish immune response assay phenotypes, maintained human cell cultures